DOAC-INT
Published by:
EDRA
Description
DOAC-INT lo strumento che ti supporta nella ricerca e valutazione delle interazioni tra anticoagulanti e altre terapie del paziente.
Informazione sul farmaco
Schede e focus scientifici sempre aggiornati, grazie al supporto delle università di Milano e Padova.
Confronto delle interazioni
Un pratico strumento per raffrontare gli anticoagulanti e i loro effetti fra loro.
Sostegno alla Terapia
Un tool guidato che ti aiuta nella scelta del miglior anticoagulante, sulla base dei farmaci del paziente.
Hide
Show More...
Informazione sul farmaco
Schede e focus scientifici sempre aggiornati, grazie al supporto delle università di Milano e Padova.
Confronto delle interazioni
Un pratico strumento per raffrontare gli anticoagulanti e i loro effetti fra loro.
Sostegno alla Terapia
Un tool guidato che ti aiuta nella scelta del miglior anticoagulante, sulla base dei farmaci del paziente.
Screenshots
DOAC-INT FAQ
-
Is DOAC-INT free?
Yes, DOAC-INT is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is DOAC-INT legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does DOAC-INT cost?
DOAC-INT is free.
-
What is DOAC-INT revenue?
To get estimated revenue of DOAC-INT app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Denmark yet.
Ratings History
DOAC-INT Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
DOAC-INT Installs
Last 30 days
DOAC-INT Revenue
Last 30 daysDOAC-INT Revenue and Downloads
Gain valuable insights into DOAC-INT performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
EDRA
- Languages
- English
- Recent release
- 1.0.2 (1 year ago )
- Released on
- Mar 17, 2023 (1 year ago )
- Also available in
- Italy , Portugal , Kazakhstan , Lebanon , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Philippines , Pakistan , Poland , Kuwait , Romania , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Finland , Australia , Belgium , Switzerland , China , Czechia , Denmark , Dominican Republic , Algeria , Egypt , Spain , United Arab Emirates , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Israel , India , Japan , South Korea
- Last Updated
- 1 week ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.